Clinical Trial Update: A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of an oxycodone/naloxone combination in Korean patients with chemotherapy-induced peripheral ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Oxycodone/Naloxone (oxycodone/naloxone)

Snippet

Sponsor: Mundipharma Korea Ltd | Conditions: Cancer | Phase 4 | Status: COMPLETED | Results posted: 2016-12-16